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Pro-tumorigenic roles of TGF- signaling during the early 
stages of liver tumorigenesis through upregulation of Snail
Hyuk Moon1, Kwang-Hyub Han2 & Simon Weonsang Ro1,*
1Institute of Gastroenterology, 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea
Many studies have focused on the tumor suppressive role of 
TGF- signaling during the early stages of tumorigenesis by 
activating the target genes involved in cytostasis and apoptosis. 
We investigated the effects of TGF- inhibition on early 
tumorigenesis in the liver, by employing diverse inhibitory 
methods. Strikingly, TGF- inhibition consistently suppressed 
hepatic tumorigenesis that was induced either by activated 
RAS plus p53 downregulation or by the co-activation of RAS 
and TAZ signaling; this demonstrates the requirements for 
canonical TGF- signaling in tumorigenesis. Moreover, we 
found that Snail is the target gene of the TGF- signaling 
pathway that promotes hepatic carcinogenesis. The knockdown 
of Snail suppressed the early tumorigenesis in the liver, as did 
the TGF- inhibition, while the ectopic expression of Snail 
restored tumorigenesis that was suppressed by the TGF- 
inhibition. Our findings establish the oncogenic TGF--Smad- 
Snail signaling axis during the early tumorigenesis in the liver. 
[BMB Reports: Perspective 2017; 50(12): 599-600]
TGF- TUMOR PROMOTION IN THE LIVER
Although studies have shown that TGF- can function as 
tumor suppressors in a variety of tissues, including the liver, 
other lines of evidence suggest that TGF- signaling promotes 
spontaneous tumorigenesis in the liver. Fibrotic and cirrhotic 
livers are highly susceptible to the development of hepato-
cellular carcinomas (HCC), which are characterized by the 
upregulation of TGF- signaling. Animal models show an 
increased spontaneous carcinogenesis in fibrotic livers which 
were induced by various fibrogenic factors, including TGF-1. 
It is largely unknown how the fibrotic/cirrhotic environment 
facilitates spontaneous liver tumorigenesis. 
We have previously shown that activation of the Sonic 
Hedgehog (SHH) signaling in the liver induced hepatic fibrosis 
and promoted HCC tumorigenesis (Chung et al., (2016) J 
Hepatol 64, 618-627). Notably, we found significant upregula-
tion of TGF- signaling and epithelial-to-mesenchymal 
transition (EMT) phenotypes in fibrotic livers induced by SHH 
activation, prior to the development of HCC. A recent study by 
Hernanda et al showed that SMAD4 expression and its nuclear 
localization are significantly elevated in HCC tissues, as 
compared with adjacent liver tissues (Hernanda et al., (2015) 
Oncogene 34, 5055-5068). In a paper recently published in 
Gastroenterology, we demonstrated that TGF- signaling can 
promote primary carcinogenesis in the liver via the up-
regulation of an EMT inducer, specifically, the Snail. We found 
that the Snail promotes cellular proliferation, as well as plays a 
critical role in the initiation of primary tumorigenesis in the 
liver. 
THE ROLE OF THE SNAIL IN THE PRIMARY 
TUMORIGENESIS IN THE LIVER
Our work shows that the Snail can initiate primary tumori-
genesis of HCC and cholangiocarcinoma (CCA), in collaboration 
with an oncogene such as an activated RAS or TAZ. 
Furthermore, the downregulation of the Snail efficiently sup-
pressed oncogene-induced primary tumorigenesis. Although 
the exact molecular mechanism by which the Snail promotes 
primary tumorigenesis in the liver remains to be determined, 
our data show that the Snail expression induced alterations in 
cell adhesion, tight junctions and the extracellular matrix, as 
well as the downregulation of E-cadherin. Disruption of tight 
junction proteins and E-cadherin can induce epithelial 
proliferation and trigger oncogenic signaling pathways. Notably, 
the genetic deletion of E-cadherin significantly contributed to 
liver tumorigenesis induced by activated RAS or a chemical 
carcinogen. Further studies are needed to elucidate the exact 
mechanism by which the Snail activates pro-tumorigenic 
signaling pathways in the liver. 
Perspective 
BMB Rep. 2017; 50(12): 599-600
www.bmbreports.org
Liver tumorigenesis by Snail
Hyuk Moon, et al.
600 BMB Reports http://bmbreports.org
CANCER INITIATION BY EMT INDUCERS
Recent studies have shed new light on the role of EMT 
inducers in cancer initiation. EMT inducers provide cancer 
cells with invasive and metastatic capabilities, thus allowing 
for the initiation of cancer at new locations. We refer to 
metastatic cancer initiation as the “initiation of secondary 
tumorigenesis (IST)” to distinguish it from the initiation of 
primary tumorigenesis. The IST capability of cancer cells is 
often evaluated using xenograft models, in which tumor cells 
which overexpress EMT inducers demonstrate an increased 
potential for cancer initiation following transplantation. 
Compared with IST, the role of EMT inducers in the 
initiation of primary tumorigenesis is less well known. 
Recently, however, several groups reported that Twist1 can 
promote spontaneous tumorigenesis in the lungs, skin, and 
mammary tissues. Twist1 has been shown to abrogate cellular 
senescence and apoptosis by repressing the p16INK4A and p53 
pathways, respectively. Supporting these inhibitory effects of 
Twist1 on senescence and apoptosis, the co-expression of 
Twist1 and activated RAS efficiently initiated the primary 
tumorigenesis in vivo. Additionally, the suppression of Twist1 
expression reactivated the senescence and apoptotic programs, 
which suppressed initiation of the primary tumorigenesis in 
the skin and lung epithelial tissues. In addition to the 
well-known roles that these entities play in metastatic cancer 
initiation, these new-found roles of EMT inducers in the 
initiation of primary tumorigenesis signify the diverse 
oncogenic effects of EMT inducers. 
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